Survival rates among breast cancer patients whose cancer is detected before it spreads are high, between 86% and 89%. Yet if ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer ...

A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...

Toon Van Gorp, MD, PhD, discusses the rationale behind and the findings from the phase 3 MIRASOL trial of mirvetuximab soravtansine in patients with folate receptor α–positive, platinum-resistant ...

Twelve-year-old Maddie Muller, in remission from ovarian cancer, walked the runway to raise awareness and support research. Diagnosed at 8 with no symptoms, she now inspires others fighting the ...

The Pershing Square Foundation (the "Foundation") today announced that it has awarded $5.25M to seven groundbreaking scientists at five premier institutions. For over a decade, the Foundation has ...

The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan, China's first domestically developed antibody-drug conjugate (ADC), for treatment of adult ...

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

This World No Tobacco Day, let's broaden the dialogue. Let's get beyond lungs and hearts and begin discussing wombs, hormones ...

Metastatic breast cancer market is projected to grow significantly through 2035, driven by rising cases, treatment advances, and expanding R&D investments.

Electricity is gaining newfound traction as a potential treatment for diseases, from rheumatoid arthritis to hard-to-treat cancers including glioblastoma and pancreatic cancer.

As 19-year-old Sarah processes her cervical cancer diagnosis on ITV's Emmerdale, these are the signs to look out for.